Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Learn smart investing strategies for stocks, ETFs, bonds, and building long-term wealth.
5,594 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Valero Energy posts a 98% capacity utilization for 2025, expands its dividend, and exits California, fueling a fresh ...
AI-driven cyber threats are accelerating, but the WisdomTree Cybersecurity Fund remains under pressure as its index c...
The Federal Reserve just paused rates, signaling a hold as markets weigh the impact on Social Security income and ret...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
Palantir shares slid about 5% as a tech-led market pullback intensified, even as the company pursued growth in govern...
Sandisk stock’s breakout looks stretched, even as AI storage demand sustains momentum. With the stock up sharply in 2...
Oil prices push above $102 per barrel as reports surface that Saudi Arabia and the UAE are weighing deeper involvemen...
The S&P 500 has slipped from its January peak, creating a dilemma for investors: chase a rebound or wait for more cla...
Figuring out what considered good stock dividends means looking beyond yield. This article breaks down the metrics th...
As the first federal reserve inflation forecast for March lands, markets wrestle with what it signals for rate paths ...